College of Human Medicine professor André Bachmann and two Corewell Health physicians, Caleb Bupp and Surender Rajasekaran, have been named the 2023 Inventors of the Year for their discovery of a previously unknown disease and development of an effective treatment. The award was presented by the New York Intellectual Property Law Association at its annual …
Built on promising work by Michigan State University scientists, MSU’s Spartan Innovation and two of the researchers have formed a company to create new treatments for neurodegenerative diseases, with a first goal of developing a gene therapy to improve care for people with Parkinson’s disease. The new startup, CavGene Therapeutics, Inc., will further research initiated …
Picture the breathtaking aerial view of Victoria Falls in Zambia — watch as water falling more than 300 feet into a seemingly endless abyss comes into focus and listen to the soothing sounds of soft music playing in the background. Relax as steam billows from the waterfall that natives call Mosi-oa-Tunya, “the smoke that thunders.” Seated …
Nanomedicines are relatively new, and we’ve only scratched the surface of their potential. “Ask the expert” articles provide information and insights from MSU scientists, researchers and scholars about national and global issues, complex research and general-interest subjects based on their areas of academic expertise and study. They may feature historical information, background, research findings or …
The process of creating new pharmaceuticals is time-consuming and expensive. Discovering a new drug and bringing it to market can take 10-15 years and costs upwards of $2.5 billion, making traditional drug discovery an area primed for innovation. Dr. Jeff MacKeigan, Assistant Dean for Research in the College of Human Medicine and Professor in the …
